Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

More documents

Recommendations

Info

19178 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) N - ATC / . DDD MON N01AX10 P 1949501 02 DIPRIVAN INJ.EM.IN 1%(10MG/ML) BTx1VIALx100ML ASTRAZENECA A N01AX10 P 1949501 03 DIPRIVAN INJ.EM.IN 1%(10MG/ML) BTx1VIALx50ML ASTRAZENECA A N01AX10 P 1949502 03 DIPRIVAN INJ.EM.IN 2% (20mg/ml) FLx50ML ASTRAZENECA A N01AX10 P 2390403 03 PROPOFOL MCT/LCT/FRINJ.EM.IN 1% (W/V) BTx5 FRESENIUS KAB N01AX10 P 2390403 05 PROPOFOL MCT/LCT/FRINJ.EM.IN 1% (W/V) BTx1 o FRESENIUS KAB N01AX10 P 2390403 08 PROPOFOL MCT/LCT/FRINJ.EM.IN 1% (W/V) BTx1 o FRESENIUS KAB N01AX10 P 2390404 05 PROPOFOL MCT/LCT/FRINJ.EM.IN 2% (W/V) BTx1 o FRESENIUS KAB N01AX10 P 2467101 01 PROPOFOL-LIPURO INJ.EM.IN 1% W/V BTx5 VIALSx20 M .. N01AX10 P 2467101 02 PROPOFOL-LIPURO INJ.EM.IN 1% W/V BOTTLEx50 ML .. N01AX10 P 2467101 03 PROPOFOL-LIPURO INJ.EM.IN 1% W/V BOTTLEx100 ML .. N01AX10 P 2467102 01 PROPOFOL-LIPURO INJ.EM.IN 2%(W/V) BTx1 BOTTLE x 5 .. N01AX10 P 2641401 02 PROPOGEN INJ.EMU 1% (10MG/ML) BTx1 VIALx50 ML GENEPHARM AE N01AX10 P 2341601 01 RECOFOL INJ.EM.IN 1%(10MG/1ML) BTx5 AMPSx20 M BAYER SCHERIN N01BA -E ( ) N01BA02 PROCAINE HYDROCHLORIDE N01BA02 P 1898402 01 INJ.SOL 100MG/10ML AM BTx50AMPSx10M DEMO ABEE N01BA02 P 1898404 01 INJ.SOL 100MG/5ML AM BTx50AMPSx5ML DEMO ABEE N01BB -A N01BB G1 -A, : ( , ) ( ) N01BB02 LIDOCAINE HYDROCHLORIDE MONOHYDRATE N01BB02 L 0057004 01 XYLOCAINE GEL 2% W/W TUBx30G ASTRAZENECA A 1 G 30.000 0.1503 4.51 4.51 ( ) N01BB01 BUPIVACAINE HYDROCHLORIDE N01BB01 B 2577002 01 BUPIVACAINE HYDROCHINJ.SOL 0.50% BTx10 AMPSx5 M BAXTER HELLAS N01BB01 B 2577002 03 BUPIVACAINE HYDROCHINJ.SOL 0.50% BTx10 AMPSx20 M BAXTER HELLAS N01BB01 B 2577003 01 BUPIVACAINE HYDROCHINJ.SOL 0.50% BTx10 AMPSx4 M BAXTER HELLAS
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 19179 N - ATC / . DDD MON N01BB02 LIDOCAINE HYDROCHLORIDE MONOHYDRATE N01BB02 L 2580401 01 SENSOLID INJ.SOL 2% W/V BTx 5 VIALS x 50M .... N01BB02 L 0057001 01 XYLOCAINE INJ.SOL 2% (20MG/ML) BTx5VIALSx50ML ASTRAZENECA A N01BB02 L 2705501 01 XYLOZAN INJ.SOL 0.02 BTX5VIALSX50M DEMO ABEE N01BB09 ROPIVACAINE HYDROCHLORIDE MONOHYDRATE N01BB09 R 2301104 01 NAROPEINE INJ.SO.INF 0,2%(2MG/1ML) BTx 5 BAGS x 100 ASTRAZENECA A N01BB09 R 2301104 02 NAROPEINE INJ.SO.INF 0,2%(2MG/1ML) BTx 5 BAGS x 200 ASTRAZENECA A N01BB09 R 2301101 01 NAROPEINE INJ.SOL 0,2%(2MG/1ML) BTx5 AMPSx10 M ASTRAZENECA A N01BB09 R 2301101 03 NAROPEINE INJ.SOL 0,2%(2MG/1ML) BTx5 AMPSx20 M ASTRAZENECA A N01BB09 R 2301102 01 NAROPEINE INJ.SOL 0,75% (7,5MG/1M BTx5 AMPSx10 M ASTRAZENECA A N01BB09 R 2301102 03 NAROPEINE INJ.SOL 0,75% (7,5MG/1M BTx5 AMPSx20 M ASTRAZENECA A N01BB09 R 2301103 01 NAROPEINE INJ.SOL 1%(10mg/1ml) BTx5 AMPSx10 M ASTRAZENECA A N01BB09 R 2301103 03 NAROPEINE INJ.SOL 1%(10mg/1ml) BTx5 AMPSx20 M ASTRAZENECA A N01BB09 R 2794702 01 ROPIVACAINE HYDROC INJ.SOL 2MG/ML BTx5 AMPS x 10M MOLTENI L. & C.D N01BB09 R 2794702 02 ROPIVACAINE HYDROC INJ.SOL 2MG/ML BTx5 AMPS x 20M MOLTENI L. & C.D N01BB09 R 2794703 01 ROPIVACAINE HYDROC INJ.SOL 7,5MG/ML BTx5 AMPS x 10M MOLTENI L. & C.D N01BB09 R 2794703 02 ROPIVACAINE HYDROC INJ.SOL 7,5MG/ML BTx5 AMPS x 20M MOLTENI L. & C.D N01BB09 R 2794704 01 ROPIVACAINE HYDROC INJ.SOL 10MG/ML BTx5 AMPS x 10M MOLTENI L. & C.D N01BB09 R 2794704 02 ROPIVACAINE HYDROC INJ.SOL 10MG/ML BTx5 AMPS x 20M MOLTENI L. & C.D N01BB09 R 2794701 01 ROPIVACAINE HYDROC SOL.INF 2MG/ML BTx 5BAGSx 100M MOLTENI L. & C.D N01BB09 R 2794701 02 ROPIVACAINE HYDROC SOL.INF 2MG/ML BTx 5BAGSx 200M MOLTENI L. & C.D N01BB10 LEVOBUPIVACAINE HYDROCHLORIDE N01BB10 L 2465202 08 CHIROCAINE IN.SO.CR 5MG/ML AMP BTx10AMPSx10M ABBVIE N01BB10 L 2465203 08 CHIROCAINE IN.SO.CR 7.5MG/1ML AMP BTX10AMPSX10M ABBVIE N01BB G2 -A, ( ) : ( , ) N01BB20 LIDOCAINE,PRILOCAINE N01BB20 L 1982101 04 EMLA CREAM 2,5%+2,5% BTx5TUBx5G+10D ASTRAZENECA A 1 G 25.000 0.4416 11.04 8.83 N01BB20 L 2717001 04 XYLOCREAM CREAM (2,5+2,5)% (W/W BT x 1 TUB x 30G VERISFIELD (UK) 1 G 30.000 0.3533 10.60 10.60 ( ) N01BB52 LIDOCAINE HYDROCHLORIDE MONOHYDRATE,EPINEPHRINE BITARTRATE N01BB52 L 0157402 01 XYLOCAINE ADRENALININJ.SOL 2%+1:200000 BT x 5 VIALS x 50 ASTRAZENECA A 0.0000 11.68 0.00
Page 1 and 2:
18959 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥ
Page 3 and 4:
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 219: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
show all

Î¥ÏÎ¿Ï ÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?

Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·